This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Angelo, L. S. Articles by Kurzrock, R. Search for Related Content PubMed PubMed Citation Articles by Angelo, L. S. Articles by Kurzrock, R.

Autocrine Interleukin-6 Production in Renal Cell Carcinoma

Evidence for the Involvement of p53

Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Interleukin (IL)-6 is an autocrine growth factor for renal cell carcinoma (RCC). We sought to determine whether p53 regulates constitutive IL-6 production. RCC cell lines containing mutant (mut) p53 produced higher levels of IL-6 than those containing wild-type (wt) p53 (P < 0.05). Transfection of wt p53 into RCC cell lines bearing mut p53 (UOK 121LN) or wt p53 (A498 and ACHN) resulted in repression of IL-6 promoter chloramphenicol acetyltransferase activity (P < 0.05). Mutant p53 was either less effective at repressing IL-6 promoter activity (ACHN cells) or enhanced IL-6 promoter activity (A498 cells). A498 cells stably transfected with mut p53 produced higher levels of IL-6 than A498 cells transfected with an empty expression vector (P < 0.05). Electrophoretic mobility shift assays showed decreased binding of CAAT enhancer binding protein, cyclic AMP responsive element binding protein, ± nuclear factor-B transcription factors to the IL-6 promoter in various RCC cell lines transfected with wt p53 (P < 0.05) but not in those transfected with mut p53. These data suggest that: (a) mutation of p53 contributes to the overexpression of IL-6 in RCC; and (b) wt p53 represses IL-6 expression, at least in part, by interfering with specific transcription factor binding to the IL-6 promoter.

This article has been cited by other articles:

				H. Zheng, L. Ye, X. Fang, B. Li, Y. Wang, X. Xiang, L. Kong, W. Wang, Y. Zeng, L. Ye, et al. Torque Teno Virus (SANBAN Isolate) ORF2 Protein Suppresses NF-{kappa}B Pathways via Interaction with I{kappa}B Kinases J. Virol., November 1, 2007; 81(21): 11917 - 11924. [Abstract] [Full Text] [PDF]

				Y. J. Lee, J. S. Heo, H. N. Suh, M. Y. Lee, and H. J. Han Interleukin-6 stimulates {alpha}-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-{kappa}B Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1036 - F1046. [Abstract] [Full Text] [PDF]

				K. Dvorak, C. M Payne, M. Chavarria, L. Ramsey, B. Dvorakova, H. Bernstein, H. Holubec, R. E Sampliner, N. Guy, A. Condon, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus Gut, June 1, 2007; 56(6): 763 - 771. [Abstract] [Full Text] [PDF]

				L. S. Angelo and R. Kurzrock Vascular Endothelial Growth Factor and Its Relationship to Inflammatory Mediators Clin. Cancer Res., May 15, 2007; 13(10): 2825 - 2830. [Abstract] [Full Text] [PDF]

				N. Dijsselbloem, S. Goriely, V. Albarani, S. Gerlo, S. Francoz, J.-C. Marine, M. Goldman, G. Haegeman, and W. V. Berghe A Critical Role for p53 in the Control of NF-{kappa}B-Dependent Gene Expression in TLR4-Stimulated Dendritic Cells Exposed to Genistein J. Immunol., April 15, 2007; 178(8): 5048 - 5057. [Abstract] [Full Text] [PDF]

				S. Ueno, S. Saito, T. Wada, K. Yamaguchi, M. Satoh, Y. Arai, and T. Miyagi Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility J. Biol. Chem., March 24, 2006; 281(12): 7756 - 7764. [Abstract] [Full Text] [PDF]

				R. Pramanik, T. N. Jorgensen, H. Xin, B. L. Kotzin, and D. Choubey Interleukin-6 Induces Expression of Ifi202, an Interferon-inducible Candidate Gene for Lupus Susceptibility J. Biol. Chem., April 16, 2004; 279(16): 16121 - 16127. [Abstract] [Full Text] [PDF]

				J. P. Russell, J. B. Engiles, and J. L. Rothstein Proinflammatory Mediators and Genetic Background in Oncogene Mediated Tumor Progression J. Immunol., April 1, 2004; 172(7): 4059 - 4067. [Abstract] [Full Text] [PDF]

				K. Dvorakova, C. M. Payne, L. Ramsey, H. Holubec, R. Sampliner, J. Dominguez, B. Dvorak, H. Bernstein, C. Bernstein, A. Prasad, et al. Increased Expression and Secretion of Interleukin-6 in Patients with Barrett's Esophagus Clin. Cancer Res., March 15, 2004; 10(6): 2020 - 2028. [Abstract] [Full Text] [PDF]

				P. C. Baer, B. Wegner, and H. Geiger Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro Nephrol. Dial. Transplant., January 1, 2004; 19(1): 47 - 52. [Abstract] [Full Text] [PDF]

				M. Trikha, R. Corringham, B. Klein, and J.-F. Rossi Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence Clin. Cancer Res., October 15, 2003; 9(13): 4653 - 4665. [Abstract] [Full Text] [PDF]

				H. Steiner, S. Godoy-Tundidor, H. Rogatsch, A. P. Berger, D. Fuchs, B. Comuzzi, G. Bartsch, A. Hobisch, and Z. Culig Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway Am. J. Pathol., February 1, 2003; 162(2): 655 - 663. [Abstract] [Full Text] [PDF]

				Y.-Y. E. Chuang, Y. Chen, Gadisetti, V. R. Chandramouli, J. A. Cook, D. Coffin, M.-H. Tsai, W. DeGraff, H. Yan, S. Zhao, et al. Gene Expression after Treatment with Hydrogen Peroxide, Menadione, or t-Butyl Hydroperoxide in Breast Cancer Cells Cancer Res., November 1, 2002; 62(21): 6246 - 6254. [Abstract] [Full Text] [PDF]